Dicerna Pharma

Dicerna Pharma

Dicerna Pharma

Dicerna Pharmaceuticals is focused on the discovery and development ofinnovative treatments for rare inherited diseases.
Type
B2c
Founded
2007
Raised
$258M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
Team Size
1–10
Employees
Xconomy , MedCity News

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

$70,000,000 Post-IPO equity
PE HUB

Dicerna scores $70 mln

Funding Stock markets